Genmab A/S
Earnings Date & Report
Last updated:
Genmab A/S’s last earnings date was on 10 May 2023.
Genmab A/S stock Earnings report, Estimates & History
| 2019-08-20 | 0.249 | 0.2 |
|---|---|---|
| 2019-11-06 | -1.75952 | 1.23 |
| 2020-02-19 | 3.43 | 3.41 |
| 2020-05-06 | 0.2897 | 0.3 |
| 2020-08-12 | 6.22 | 7.58 |
| 2020-11-11 | 0.2434 | 0.13 |
| 2021-02-23 | 0.2647 | 0.14 |
| 2021-05-21 | 0.225 | 0.27 |
| 2021-08-11 | 0.08 | 0.08 |
| 2021-11-10 | 0.21 | 0.21 |
| 2022-02-16 | 0.3347 | 0.17 |
| 2022-05-11 | 0.2072 | 0.11 |
| 2022-08-10 | 0.712 | 0.41 |
| 2022-11-09 | 1.65 | 0.53 |
| 2023-02-22 | 0.2354 | 0.12 |
Estimated - a value of Apple’s earnings per share estimated by analysts based on its past and current financial statements.
Reported - a real value of Apple’s earnings per share reported by the company.
Genmab A/S stock earnings history by quarter
| Date | Estimated EPS | Reported EPS | Estimated revenue | Actual revenue | Earnings call | |
|---|---|---|---|---|---|---|
| 10 May 2023 | N/A | $0.09 | N/A | N/A | N/A | Earnings Call Transcript |
| 22 Feb 2023 | Missed | $0.24 | $0.12 | 671.21M | 5.22B | Earnings Call Transcript |
| 31 Dec 2022 | N/A | N/A | $0.89 | N/A | 5.22B | |
| 9 Nov 2022 | Missed | $1.65 | $0.53 | N/A | 4.08B | Earnings Call Transcript |
| 10 Aug 2022 | Missed | $0.71 | $0.41 | N/A | 4.08B | Earnings Call Transcript |
| 11 May 2022 | Missed | $0.21 | $0.11 | 319.58M | 3.16B | Earnings Call Transcript |
| 16 Feb 2022 | Missed | $0.33 | $0.17 | 319.58M | 2.11B | Earnings Call Transcript |
| 10 Nov 2021 | Matched | $0.21 | $0.21 | 1.75B | 2.61B | Earnings Call Transcript |
| 11 Aug 2021 | Matched | $0.08 | $0.08 | 319.58M | 2.31B | Earnings Call Transcript |
| 21 May 2021 | Beat | $0.23 | $0.27 | 1.30B | 1.97B | |
| 23 Feb 2021 | Missed | $0.26 | $0.14 | 3.45B | 1.58B | Earnings Call Transcript |
| 11 Nov 2020 | Missed | $0.24 | $0.13 | 2.89B | 2.04B | |
| 12 Aug 2020 | Beat | $6.22 | $7.58 | 1.46B | 1.72B | Earnings Call Transcript |
| 6 May 2020 | Beat | $0.29 | $0.3 | 5.26B | 5.45B | |
| 19 Feb 2020 | Missed | $3.43 | $3.41 | 2.97B | 892M | |
| 6 Nov 2019 | Beat | -$1.76 | $1.23 | 1.32B | 2.96B | |
| 20 Aug 2019 | Missed | $0.25 | $0.2 | 974.55M | 1.03B | |
| 30 Jun 2019 | N/A | N/A | $0.14 | N/A | 773.91M | |
| 31 Mar 2019 | N/A | N/A | $0.12 | N/A | 591.00M | |
| 31 Dec 2018 | N/A | N/A | $1.36 | N/A | 1.23B | |
Genmab A/S Earnings report FAQs
When is Genmab A/S's next Earnings date?
The company has not set the next earnings date yet. The latest Genmab A/S's earnings date was on 10 Aug 2022.
What are earnings?
Earnings are the net income of a company after all taxes and expenses have been deducted. They are the main figure for determining the price of a company's shares.
What does EPS stand for?
EPS stands for earnings per share, which is the basic measure of a company's earnings. It indicates how much money each share earned for the company.
How to calculate earnings per share?
Earnings per share (EPS) can be calculated by dividing a company's net income by the number of common shares outstanding. If the company pays preferred dividends, they are first subtracted from the company’s net income.
Formula:
What is earnings per share estimate?
Earnings estimate is analysts’ prediction of a company’s earnings value in the next quarter or fiscal year based on past and current financial statements of a company. It is an important indicator for both current and future investors.